Canadian Healthcare Technology Logo
  • Issues
    • Current Print Issue
    • Print Archive
  • Advertise
    • Publishing Schedule
    • Circulation
    • Unit Sizes and Rates
    • Mechanical Requirements
    • Electronic Advertising
    • White Papers
  • Subscribe
    • Print Edition
    • e-Messenger
    • White Papers
  • Events
  • Vendors
  • About Us

GE Revolution Ascend

GE Revolution Ascend

Enovacom EPC

Enovacom EPC

Innovation

ACOA lends $3 million to develop portable lab

April 24, 2019


Alan FineHALIFAX – The Atlantic Canada Opportunities Agency is providing a $2.99 million loan to Alentic Microscience Inc., which has devised a pocket-sized diagnostic device that can generate test results in under five minutes, from any location, using only a drop of blood from a pinprick.

In collaboration with Honeywell International Inc., Alentic obtained a multi-million dollar contract with the Canadian Space Agency to develop specific diagnostic tests and a device to monitor astronauts’ immune systems in real time, according to a news release by the Atlantic Canada Opportunities Agency.

“All of us at Alentic Microscience are deeply grateful to ACOA for their enabling financial support. This contribution will allow us to achieve critical research, development and commercialization milestones on our path to selling Alentic’s revolutionary diagnostic devices in Canada and abroad. The money further allows us to grow our superb team as we approach market entry,” said Alan Fine (pictured), CEO, Alentic Microscience.

The loan through ACOA’s Business Development Program will help create six jobs, including a biological engineer, a software developer and an embedded systems engineer, in addition to maintaining 15 jobs, to help with the planning, detailed design, prototype assembly, testing and clinical trials of new devices.

Alentic is now commercializing its technology to be used in hospitals, clinics, veterinary settings or in the field.

The device uses patented technology to analyze a tiny quantity of blood, producing high quality blood test results immediately at patient point-of-care. The device can perform different types of tests rapidly, which will improve patient care, reduce wait times, lower costs and increase healthcare efficiencies, according to the federal development agency.

Alentic Microscience has been granted 10 patents in the United States, one in Canada and one in China, with many more patents in progress.

Alan Fine is a professor of physiology and biophysics and biomedical engineering at Dalhousie University. Dr. Fine has studied optical imaging for most of his career. His newest device was inspired by his pioneering work in lensless microscopy, an optical imaging technique that avoids the blurring caused by light diffraction that affects even the most powerful lens-based microscopes.

Lensless microscopy can be used to look deep inside human tissue and is particularly suited to studying living cells. It has become an essential tool for Dr. Fine, whose research focuses on the cellular dynamics of how the brain processes and stores information.

Said to be simple to use, a fraction of the size and costing orders of magnitude less than traditional diagnostic equipment, Dr. Fine’s lensless device is a potential game-changer in both clinical and industrial applications. The technology is now being refined and tested by Alentic Microscience Inc., a start-up company founded by Dr. Fine and his research team.

PreviousNext

SteraMist (Feb)

SteraMist (Feb)

News and Trends

  • Eastern Ontario hospitals up-and-running on Epic system
  • Osler’s iHuddle app facilitates team communication, collaboration
  • DI: How will radiology change five years from now?
  • Hospitals and imaging centres are grappling with DI backlogs
  • RACE streamlines patient journey
More from the Print Edition

Subscribe

Subscribe

Free of charge to Canadian hospital managers and executives in nursing homes and home-care organizations. Learn More

Follow us on Social Media!

Follow us on Social Media!

Nihi Data [Winter 2023]

Nihi Data [Winter 2023]

WP

WP

Advertise with us

Advertise with us

Sectra One Cloud

Sectra One Cloud

Change Healthcare [2]

Change Healthcare [2]

Infoway [Feb2023]

Infoway [Feb2023]

Zebra

Zebra

CHT print-200×400

CHT print-200x400

SteraMist (Feb)

SteraMist (Feb)

Advertise with us

Advertise with us

Sectra One Cloud

Sectra One Cloud

Change Healthcare [2]

Change Healthcare [2]

Infoway [Feb2023]

Infoway [Feb2023]

Zebra

Zebra

CHT print-200×400

CHT print-200x400

Contact Us

Canadian Healthcare Technology
1118 Centre Street, Suite 207
Thornhill, Ontario, Canada L4J 7R9
Tel: 905-709-2330
Fax: 905-709-2258
info2@canhealth.com

  • Quick Links
    • Current Print Issue
    • Print Archive
    • Events
    • Vendors
    • About Us
  • Advertise
    • Publishing Schedule
    • Circulation
    • Unit Sizes and Rates
    • Mechanical Requirements
    • Electronic Advertising
    • White Papers
  • Subscribe
    • Print Edition
    • e-Messenger
    • White Papers
  • Resources
    • White Papers
    • Writers’ Guidelines
    • Privacy Policy
  • Topics
    • Administrative Solutions
    • Clinical Solutions
    • Companies
    • Continuing Care
    • Diagnostics
    • Education & Training
  •  
    • Electronic Records
    • Government & Policy
    • Infrastructure
    • Innovation
    • People
    • Privacy and Security

© 2023 Canadian Healthcare Technology

The content of Canadian Healthcare Technology is subject to copyright. Reproduction in whole or in part without prior written permission is strictly prohibited. Send all requests for permission to Jerry Zeidenberg, Publisher.

Search Site

Error: Enter a search term

  • Issues
    • Current Print Issue
    • Print Archive
  • Advertise
    • Publishing Schedule
    • Circulation
    • Unit Sizes and Rates
    • Mechanical Requirements
    • Electronic Advertising
    • White Papers
  • Subscribe
    • Print Edition
    • e-Messenger
    • White Papers
  • Events
  • Vendors
  • About Us